TO FIND THE PREVALENCE OF AUTONOMIC NEUROPATHY IN PATIENTS WITH NON ALCOHOLIC HEPATIC CIRRHOSIS

Similar documents
A Study on The Prevalence of Cardiac Autonomic Neuropathy in Type-2 Diabetes in Eastern India

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine

Approach to Abnormal Liver Tests

Patterns of abnormal LFTs and their differential diagnosis

ELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

Blood Pressure. Blood Pressure (mm Hg) pressure exerted by blood against arterial walls. Blood Pressure. Blood Pressure

Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Guidelines for the management of hypertension in patients with diabetes mellitus

Effect of smoking on sustained handgrip test and valsalva ratio among smokers: A cross sectional study

*6816* 6816 CONSENT FOR DECEASED KIDNEY DONOR ORGAN OPTIONS

Local Coverage Determination (LCD): Medicine: Autonomic Function Tests (L34500)

Overview of the Adverse Childhood Experiences (ACE) Study. Robert F. Anda, MD, MS Co-Principal Investigator.

Autonomic dysfunctions in Paralympic athletes.

Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care

Relationship Between Child Abuse, Substance Abuse and Violence

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

Common Ventilator Management Issues

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto

Kanawha Valley Fellowship Home

Liver Function Essay

Preoperative Laboratory and Diagnostic Studies

Acute on Chronic Liver Failure: Current Concepts. Disclosures

What Alcohol Does to the Body. Chapter 25 Lesson 2

Cirrhosis and HCV. Jonathan Israel M.D.

Anticoagulants in Atrial Fibrillation

Update on Hepatitis C. Sally Williams MD

Barostimulaatio ja renaalinen denervaatio

High Blood Pressure (Essential Hypertension)

BURDEN OF LIVER DISEASE IN BRAZIL

An Investigation of Alcohol Metabolizing Enzyme Genes in Chinese Alcoholics With Pancreatitis,, Cirrhosis of Liver, and Avascular Necrosis of Hip

Living with Low Blood Pressure

Alcohol Overuse and Abuse

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

Developing Innovative Therapeutics for People with Orphan Liver Disease

Alcohol Facts and Statistics

JAMAICA. Recorded adult per capita consumption (age 15+) Last year abstainers

You can relax, knowing your final wishes will be respected.

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Risk Factors for Alcoholism among Taiwanese Aborigines

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

Substance Abuse in the Elderly

New Anticoagulants and GI bleeding

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

THE NEW INTERCEPT STRATEGY FOR OCA AND THE IMPACT OF GENFIT- GFT505 MARKET

Written Example for Research Question: How is caffeine consumption associated with memory?

Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP

EVALUATION OF LIVER FIBROSIS BY FIBROSCAN

Surveillance for Hepatocellular Carcinoma

Correspondence to: Rima B Shah (rima_1223@yahoo.co.in) DOI: /ijmsph Received Date: Accepted Date:

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Which drugs should be used to treat diabetes in cirrhotic patients?

How To Know If You Have Microalbuminuria

Drug Associated Deaths

Low Blood Pressure. This reference summary explains low blood pressure and how it can be prevented and controlled.

Boehringer Ingelheim- sponsored Satellite Symposium. HCV Beyond the Liver

Results Demographic profile of these children is shown in Table I.

DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa

King County EMS Stroke Quality Improvement Program

ECG may be indicated for patients with cardiovascular risk factors

HEPATIC ENCEPHALOPATHY

Short Term Effects of Coconut Water and Cocoa on Blood Pressure

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options?

Non-response bias in a lifestyle survey

2015 CLASS RESULTS FOR BLOOD PRESSURE LAB. PART I: Changes in Posture

Alanine aminotransferase (serum, plasma)

How To Determine The Prevalence Of Microalbuminuria

HEALTH TRANSITION AND ECONOMIC GROWTH IN SRI LANKA LESSONS OF THE PAST AND EMERGING ISSUES

Alcohol Facts and Statistics

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness SOGH April

Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions

Neuroscience of psychosomatic medicine: cardiovascular risk. Hugo Critchley

Estimation of Sympathetic and Parasympathetic Level during Orthostatic Stress using Artificial Neural Networks

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis

Vtial sign #1: PULSE. Vital Signs: Assessment and Interpretation. Factors that influence pulse rate: Importance of Vital Signs

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

Non-alcoholic fatty liver disease: Prognosis and Treatment

The insurance company checked above (Company) is responsible for the obligation and payment of benefits under any policy that it may issue.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

Huron County Community Health Profile

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD

Observational Cross Sectional Study on Blood Donors

National Health Burden of CLD in Italy

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Psychosocial and Clinical Aspects of Eating Disorder in Young Females. Khoo P.J. 1 and Ho T.F. 2

Science Highlights. To PSA or not to PSA: That is the Question.

African Americans & Cardiovascular Diseases

Use of antihypertensive medications in patients with diabetes in Ajman, UAE

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Important Information When Considering Portability Coverage

What You Don t Know Can Harm You

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

Questionnaire: Use of placebo-medication for treating depression. 1. Explanation about the Placebo Treatment for Depression

Management of non response or relapse following HCV therapy. Greg Dore Darrell Crawford

Transcription:

TO FIND THE PREVALENCE OF AUTONOMIC NEUROPATHY IN PATIENTS WITH NON ALCOHOLIC HEPATIC CIRRHOSIS Deepak Garg, Devinder Singh Mahajan, Ashok Khurana, Jang Bahadar Singh 1. Junior Resident. Department of Medicine, Sri Guru Ram Das Institute of Medical Sciences and Research, 2. Professor. Department of Medicine, Sri Guru Ram Das Institute of Medical Sciences and Research, 3. Professor. Department of Medicine, Sri Guru Ram Das Institute of Medical Sciences and Research, 4. Senior Resident. Department of Medicine, Sri Guru Ram Das Institute of Medical Sciences and Research, CORRESPONDING AUTHOR Dr. Deepak Garg, House no. 1843, St. No. 8-G, Dasmesh Nagar, Moga- 142001. E-mail: deepaksir1985@yahoo.in Ph: 0091 9646009050 ABSTARCT: Autonomic neuropathy has been reported in patients with alcoholic liver disease but information on its occurrence in patients with non-alcoholic liver disease is contradictory. To make the things more clear the present study was conducted to assess autonomic functions in patients with non-alcoholic liver disease and its relationships with the severity of liver damage. Autonomic function using five standard tests was examined in 50 cirrhotics. The extent of autonomic dysfunction was determined in the patients and a comparison between the characteristics of patients with and without autonomic neuropathy was made. Out of 50 patients 35 (70%) were found to have autonomic neuropathy The alteration of the parasympathetic function [20 out of 35(57%)] was significantly more frequent than that of sympathetic function [15(43%)]. The prevalence of autonomic neuropathy was more (80%) in patients with Child-Pugh grade C cirrhosis as compared to those having Child-Pugh grade B cirrhosis (54%). The results were clinically significant but statistically insignificant (p>0.05). It was seen that out of total 50 cases of non alcoholic cirrhosis, the majority (68%) were due to hepatitis C infection. A high prevalence of abnormalities in both sympathetic and parasympathetic function tests, and a poor relationship with liver function parameters, has been found in patients with non-alcoholic chronic liver disease. KEY WORDS : Autonomic neuropathy, hepatic cirrhosis, hepatitis, Child Pugh class INTRODUCTION: Cirrhosis leads to a number of complications, some of which eventually prove fatal. Autonomic neuropathy has been discovered to be one of such culprit. It is a known complication of many diseases such as diabetes and alcohol abuse. It has been well established in cirrhosis by various studies. Autonomic dysfunction in advanced liver disease is associated with decreased baroreceptor sensitivity to hypotension, leading to impaired blood pressure & heart rate responses. Page-1035

MATERIAL AND METHODS: The study was based on 50 patients with non alcoholic hepatic cirrhosis. EXCLUSION CRITERIA: 1. Subjects known to have consumed alcohol. 2. Subjects on drugs known to cause autonomic neuropathy like antihypertensives, anticholinergics, nitrates, ACE inhibitors, antidepressants, tranquilizers, barbiturates. 3. Those with a history of diabetes mellitus. 4. Ischemic heart disease and other medical conditions which could confound the interpretation of autonomic function tests in relation to cirrhosis. 5. Those unable to tolerate with drawl of diuretics one week prior to tests. 6. Those who were unable to cooperate during the performance of autonomic function tests were excluded from the study. All patients were subjected to a battery of 5 standard autonomic tests as detailed below: Tests reflecting parasympathetic damage: 1) Heart rate response to valsalva maneuver. 2) Heart rate (R-R) variation during deep breathing. 3) Immediate heart rate response to standing. Tests reflecting sympathetic damage: 4) Blood pressure response to standing. 5) Blood pressure response to sustained handgrip. Interpretation of tests was based on the works of Ewing and Clarke Child and Turcotte (later modified by Pugh and named Child and Pugh) criteria were used in study to quantify the liver damage in the patients. ETHICS While performing this study on human subjects, the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975 that was revised in 2000. RESULTS: The present study included 50 patients of hepatic cirrhosis who did not consume alcohol. There were almost equal number of male (44%) and female (56%) patients with majority of the patients in age group of 50-75 yrs. The mean age was 57.20 ± 4.38 years. This was seen that the major cause of non alcoholic cirrhosis was Hepatitis C accounting for 68% of the cases. Out of 50 cases of cirrhosis there was no patient in the Child-Pugh class A. The majority of the patients (80%) belonged to Child-Pugh class B. Out of them 54% had evidence of autonomic neuropathy. 20% of the patients belonged to class C. Out of those, 80% had evidence of neuropathy (p >0.05). Out of 50 cases, majority 35 (70%) of the patients had either borderline 14 (28%) or normal 21 (42%) valsalva ratio. The abnormal value (<1.10) was present in 15(30%) of the patients. The mean valsalva ratio was 1.166 ± 0.035. The minimum value was 0.97 and the maximum one was 1.64. Out of 40 patients of Child-Pugh class B, 30(75%) had an normal valsalva ratio whereas 10(25%) had an abnormal ratio. Out of 10 Page-1036

patients of Child-Pugh class C, 5(50%) had an normal valsalva ratio and 5(50%) had an abnormal ratio. The results thus obtained were not significant with a p value>0.05. Heart rate variation during deep breathing was normal (>15 beats/min) in 70% of the patients out of the total 50 patients. There was no patient in the borderline group. 30% of the patients had an abnormal (<10 beats/min) heart rate variation. The mean value was 15.80 ± 1.74 beats/min. The minimum value was 5.67 and the maximum was 26 beats/min. Out of 40 patients of Child-Pugh class B, 29(72.5%) had an normal H-R variation during deep breathing whereas 11(27.5%) had an abnormal response. Out of 10 patients of Child-Pugh class C, 6(60%) had an normal H-R variation during deep breathing and 4(40%) had an abnormal response. The results thus obtained were not significant (p>0.05). Out of 50 patients, 50% had an abnormal heart response to immediate standing. Only 2% were in the borderline group, and the rest 48% had normal response. The mean value was 1.07 ± 0.06. The highest value was 1.92 and the lowest was 0.90. Out of 40 patients of Child- Pugh class B, 19(47.5%) had an normal immediate heart response to standing whereas 21(52.5%) had an abnormal response. Out of 10 patients of Child-Pugh class C, 6(60%) had an normal immediate heart response to standing (30:15) and 4(40%) had an abnormal response. The results thus obtained were not significant with a p value >0.05 None of the patient had abnormal blood pressure response to standing. It was evident in our study that 30% of the total patients had an abnormal blood pressure response to sustained hand grip. Rest 70% had an normal response. The mean value was 15.73 ± 1.54. The minimum value was 6.67 and the maximum was 24.. Out of 40 patients of Child-Pugh class B), 28(70%) had an normal blood pressure response to sustained hand grip (increase in diastolic pressure in mm Hg) whereas 12(30%) had an abnormal response. Out of 10 patients of Child-Pugh class C), 7(70%) had an normal B.P response to sustained hand grip (increase in diastolic pressure in mm Hg) and 3(30%) had an abnormal response. The results thus obtained were not significant with a p value>0.05. DISCUSSION: In the present study, 35 out of 50 cases (70%) of non alcoholic hepatic cirrhosis were found to have an abnormal result in one or more autonomic function tests. 10 cases (20%) had evidence of early parasympathetic damage, 10 cases (20%) had definite parasympathetic damage and 15 cases (35%) had combined (i.e both sympathetic and parasympathetic damage). These observations are consistent with the studies done by Gentile et al, 3 Hendickse, Thuluvah and Triger et al.4 Out of the 10 patients with early parasympathetic damage, 6 (60%) belonged to Child-Pugh class B whereas 4 (40%) to Child-Pugh class C. While in 10 patients with definite parasympathetic damage, 9 (90%) belonged to Child-Pugh class B whereas 1 (10%) to Child- Pugh class C and in 15 patients with combined damage, 12 (80%) belonged to Child-Pugh class B whereas 3 (20%) to Child-Pugh class C. In total of 35 patients having autonomic neuropathy, 27(77%) belonged to Child-Pugh class B, whereas 8(23%) belonged to Child-Pugh class C. In the present study there was no patient in the Child-Pugh class A. 80% of the patients belonged to Child-Pugh class B. 20% of the patients belonged to class C. Out of 80% patients of Child-Pugh class B, 54% had evidence of neuropathy. Out of those 20% patients of Child-Pugh class C, 80% had evidence of neuropathy. The mean C-P score was 8.70 ± 0.32 (p>0.05). These findings are similar to observations of Bajaj5 and Oliver6 studies which reported increasing frequency of autonomic dysfunction with increasing severity of liver damage. In the present study, heart rate response to standing was the most frequently (25 out of 50 patients) abnormal tests in cirrhotics. This is in consistence with the study by Barter and Page-1037

Tanner7 in their study on 30 patients of chronic liver disease in relation to autonomic neuropathy noted the heart-rate response to standing as the most sensitive test with high specificity. The results were clinically significant but most probably due to a significant variation in number of patients in Child Pugh class A, B and C ( p = 0.315) the results came out to be statistically non significant. CONCLUSION: The burden of cirrhosis in India is enormous with majority of them presenting in later stages of the disease. Hepatitis C has emerged to be a major cause of non alcoholic cirrhosis. Autonomic neuropathy is present in nearly 70 percent of the patients which is a potential cause of many of the complications. An exhaustive clinical examination and some cost effective screening tests are sufficient to detect this problem in earlier stages, which can be instrumental in better care of the patients. REFRENCES: 1. Laennec RTH. Traite de l auscultation mediate. Paris, Chaude, 1826:196 2. Rossle R. In: Henke F, Lubarsch O, eds. Handbuch der Spezillen Pathologischen Anatomie und Histologie, vol 5, part 1. Julius Springer, Berlin. 1930 3. Gentile S. Autonomic neuropathy in liver disease: relationship with alcoholic etiology and severity of disease. Italy J Gastroenterol 1994;(2):53. 4. Hendrickse MT, Thuluvath PJ, Triger DR. Natural history of autonomic neuropathy in chronic liver disease. Lancet 1992;339:1462 5. B K Bajaj, M P Agarwal, B Krishna Ram. Autonomic neuropathy in patients with hepatic cirrhosis.. Postgrad Med J 2003;79:408-411 6. Oliver, E.M Brunt, et al. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol.2004;35(9):1070-1082 7. Barter F, Tanner AR. Autonomic Neuropathy in an alcoholic population. Postgrad Med J 1987;63:1033. Page-1038

Child-Pugh class Autonomic 0 No. of Patients 13 2 Neuropathy % of patients with no neuropathy 86.7% 13.3% % of patients within respective Child-Pugh classes 32.5% 20.0% 1 No. of Patients 6 4 % of patients with early parasympathetic damage 60.0% 40.0% % of patients within respective Child-Pugh classes 15.0% 40.0% 2 No. of Patients 9 1 % of patients with definite parasympathetic damage 90.0% 10.0% % of patients within respective Child-Pugh classes 22.5% 10.0% 3 No. of Patients 12 3 % of patients with combined damage 80.0% 20.0% % of patients within respective Child-Pugh classes 30.0% 30.0% Total No. of Patients 40 10 % within autonomic neuropathy 80.0% 20.0% % of patients within respective Child-Pugh classes 100.0% 100.0% (0-No neuropathy. 1- early parasympathetic damage, 2- definite parasympathetic damage, 3- combined damage) B C Page-1039